omniture
ARC THERAPIES株式会社

Latest News

ARC Therapies Advances Gut Microbiome Research with YB328 Toward Clinical Application

Investigating Its Role as an Immune Adjuvant in Cancer Immunotherapy TOKYO, Aug. 20, 2025 /PRNewswi...

2025-08-20 07:00 1819

Initiation of cell therapy research and development program for adult T-Cell leukemia / lymphoma (ATLL)

Initiation of cell therapy research and development program for adult T-Cell leukemia / lymphoma (...

2024-07-11 14:24 3143

Initiation of cell therapy research and development program for adult T-Cell leukemia / lymphoma (ATLL)

Initiation of cell therapy research and development program for adult T-Cell leukemia / lymphoma (...

2024-07-11 14:21 2486